MedTrace Logo

Obex, a Nutritional Supplement, in Overweight and Obese Spanish Women

NCT01934036 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2014-02-25

No results posted yet for this study

Summary

The aim of the study is to evaluate the effects of a dietary supplement (Obex®) on anthropometric and physiological variables in Spanish women between 35 and 60 years who are overweight or obese.

Conditions

Interventions

DIETARY_SUPPLEMENT

Obex

After concluded the two months of treatment, patients will be follow-up during three months without consumption of Obex.

DRUG

Placebo

After concluded the two months of treatment, patients will be follow-up during three months without consumption of the placebo.

Sponsors & Collaborators

  • Catalysis SL

    lead INDUSTRY

Principal Investigators

  • Consuelo Prado, Ph.D. · Universidad Autonónoma de Madrid

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Spain

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01934036 on ClinicalTrials.gov